動物鎮靜劑市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、給藥途徑、地區和競爭細分，2020-2030 年預測

2024 年全球動物鎮靜劑市場價值為 1.3204 億美元，預計到 2030 年將達到 1.7386 億美元，預測期內複合年成長率為 4.65%。在 COVID-19 疫情爆發初期，動物鎮靜劑市場出現了明顯混亂。這主要是由於世界各國政府廣泛實施了封鎖、保持社交距離等遏制措施，大大減少了獸醫院和藥房的運作。例如，Faunalytics 在 2022 年 12 月進行的一項研究顯示，為了防止疫情期間的疾病傳播，美國和加拿大約 70% 的診所暫時停止了對公眾開放，導致動物不得不在沒有主人或監護人陪同的情況下就診。

主要市場促進因素

增加寵物擁有量

主要市場挑戰

倫理問題

主要市場趨勢

鎮靜劑配方的進展

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球動物鎮靜劑市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依類型（乙醯丙嗪、布托啡諾、地托咪啶、羅米菲定、賽拉嗪）
  • 依給藥途徑（口服、腸胃外）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第 6 章：北美動物鎮靜劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第7章：歐洲動物鎮靜劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太動物鎮靜劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲動物鎮靜劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲動物鎮靜劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如果有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Zoetis Inc
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Elanco Animal Health Inc
• Virbac SA
• Dechra Pharmaceuticals Limited
• Orion Corporation
• Vetoquinol SA
• Bimeda, Inc.
• Chanelle Pharma Group

第 15 章：策略建議

第16章 關於出版商,免責事項

Global Animal Sedative Market was valued at USD 132.04 Million in 2024 and is expected to reach USD 173.86 Million by 2030 with a CAGR of 4.65% during the forecast period. The animal sedative market saw a notable disruption during the initial phase of the COVID-19 pandemic. This was primarily due to the extensive implementation of containment measures like lockdowns and social distancing by governments worldwide, which significantly reduced the operations of veterinary hospitals and pharmacies. For instance, a study conducted by Faunalytics in December 2022 revealed that in order to prevent disease transmission during the pandemic, approximately 70% of clinics in the United States and Canada temporarily suspended public access, leading to situations where animals had to attend appointments without their owners or guardians.

Key Market Drivers

Increasing Pet Ownership

Pet ownership has become a global phenomenon, with millions of households worldwide welcoming furry, feathered, or scaly companions into their lives. This surge in pet ownership is not just about companionship; it's also driving growth in various industries, including veterinary care and pharmaceuticals.

As more people open their homes to pets, there is a growing emphasis on pet healthcare. Pet owners are increasingly recognizing the importance of regular veterinary check-ups, vaccinations, and surgical procedures when needed. For these medical interventions, sedation is often required to ensure the safety and comfort of the animals. In May 2023, Virbac acquired GS Partners, its long-term distributor in the Czech Republic and Slovakia, marking its 35th subsidiary and strengthening its position in Central Europe. This acquisition aims to boost Virbac's capacity to address the animal health needs in the region, particularly focusing on the pet and ruminant sectors.

Key Market Challenges

Ethical Concerns

Ethical concerns surrounding animal testing are a growing issue in the veterinary and pharmaceutical industries, raising questions about the morality and necessity of using animals for testing purposes. The use of animals to test the safety and efficacy of new sedatives, vaccines, and other treatments presents a delicate balance between ensuring product effectiveness and minimizing harm to animals. As consumers and regulatory bodies place increasing importance on animal welfare, companies in the industry are under pressure to adopt more humane practices. Many organizations are prioritizing the reduction of animal testing through the development and implementation of alternative testing methods, such as in vitro models, organ-on-a-chip technologies, and computer simulations. These advancements offer potential solutions to alleviate the ethical burden by providing more reliable, humane alternatives. Nonetheless, it is still an ongoing challenge to ensure that these alternatives meet the rigorous standards required for veterinary treatments while still maintaining the highest level of animal welfare possible.

Key Market Trends

Advancements in Sedative Formulations

Recent innovations in pharmaceutical research have led to the development of more effective, safer, and faster-acting sedatives for veterinary use. These advancements are revolutionizing the way sedation is administered in animals, improving the quality of care and reducing the risks associated with traditional sedatives. New formulations are designed to not only act more quickly but also to minimize side effects, such as post-sedation confusion or extended recovery times, which can sometimes occur with older sedative agents. These newer sedatives often provide better control over the depth and duration of sedation, allowing veterinarians to perform procedures with greater precision and confidence. In November 2022, SeQuent Scientific Limited (SeQuent), a prominent Indian company specializing in animal health products, particularly veterinary formulations and APIs, entered into a binding agreement to purchase the entire ownership stake, equivalent to 100%, in Tineta Pharma Private Limited (Tineta), an Indian-based company.

Additionally, many of these advanced formulations are designed with a lower risk of adverse reactions, reducing the likelihood of complications during or after the procedure. This ensures a safer overall experience for the animal, leading to quicker recovery times and less stress on both the animal and the veterinary team. The continued research and development in sedative formulations are making veterinary procedures more efficient, safer, and more comfortable for animals, improving both clinical outcomes and the overall experience for veterinary professionals.

Key Market Players

• Zoetis Inc
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Elanco Animal Health Inc
• Virbac S.A.
• Dechra Pharmaceuticals Limited
• Orion Corporation
• Vetoquinol SA
• Bimeda, Inc.
• Chanelle Pharma Group

Report Scope:

In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Sedative Market, By Type:

• Acepromazine
• Butorphanol
• Detomidine
• Romifidine
• Xylazine

Animal Sedative Market, By Route of Administration:

• Oral
• Parenteral

Animal Sedative Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.

Available Customizations:

Global Animal Sedative market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Sedative Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
  • 5.2.2. By Route of Administration (Oral, Parenteral)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Animal Sedative Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Route Of Administration
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Sedative Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Route Of Administration
  • 6.3.2. Canada Animal Sedative Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Route Of Administration
  • 6.3.3. Mexico Animal Sedative Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Route Of Administration

7. Europe Animal Sedative Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Route Of Administration
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Sedative Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Route Of Administration
  • 7.3.2. United Kingdom Animal Sedative Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Route Of Administration
  • 7.3.3. Italy Animal Sedative Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Route Of Administration
  • 7.3.4. France Animal Sedative Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Route Of Administration
  • 7.3.5. Spain Animal Sedative Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Route Of Administration

8. Asia-Pacific Animal Sedative Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Route Of Administration
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Animal Sedative Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Route Of Administration
  • 8.3.2. India Animal Sedative Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Route Of Administration
  • 8.3.3. Japan Animal Sedative Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Route Of Administration
  • 8.3.4. South Korea Animal Sedative Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Route Of Administration
  • 8.3.5. Australia Animal Sedative Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Route Of Administration

9. South America Animal Sedative Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Route Of Administration
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Animal Sedative Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Route Of Administration
  • 9.3.2. Argentina Animal Sedative Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Route Of Administration
  • 9.3.3. Colombia Animal Sedative Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Route Of Administration

10. Middle East and Africa Animal Sedative Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Route Of Administration
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Animal Sedative Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Route Of Administration
  • 10.3.2. Saudi Arabia Animal Sedative Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Route Of Administration
  • 10.3.3. UAE Animal Sedative Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Route Of Administration

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Boehringer Ingelheim International GmbH
• 14.3. Merck & Co., Inc.
• 14.4. Elanco Animal Health Inc
• 14.5. Virbac S.A.
• 14.6. Dechra Pharmaceuticals Limited
• 14.7. Orion Corporation
• 14.8. Vetoquinol SA
• 14.9. Bimeda, Inc.
• 14.10. Chanelle Pharma Group

15. Strategic Recommendations

16. About Us & Disclaimer